Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Christopher Pasquale Profile - Nephron Analyst
158 Followers
Christopher Pasquale Nephron
Wall Street Analyst
Success Rate
68 out of 108 ratings made a profit
Average Return
+12.80%
Average return per rating
Time Frame
Compare to
Copying Christopher Pasquale's trades since 2013 and holding each position for 1 Year would result in 62.96% of your transactions generating a profit, with an average return of 12.8% per rating.
Stock Rating Distribution
79.50% Buy
20.50% Hold
0.00% Sell
Distribution of Christopher Pasquale's ratings
Additional Information
Main Sector:Healthcare
Geo Coverage:
US Market
US MarketBest Rating
Stock:
Abiomed, Inc.
(ABMD)
(ABMD)
Rating:Buy
Date:May 04, 2017 - May 04, 2018
Return:+167.00%
The most profitable rating made by Christopher Pasquale
Christopher Pasquale's Stock Coverage
List of latest recommendations made by Christopher Pasquale. Click to expand and see Christopher Pasquale's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >Christopher Pasquale activity FAQ
What is the performance of Christopher Pasquale's recommendations?
The percentage of profitable recommendations made by Christopher Pasquale is 63%, and the average return per transaction is 12.80%.
What stocks does Christopher Pasquale cover?
What was Christopher Pasquale's most profitable rating?
Christopher Pasquale’s most profitable ratings was a buy on ABMD stock on May 04, 2017 - May 04, 2018. The return on the trade was +167.00%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here